Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest stroke Stories

2013-12-05 23:31:53

Paula J. Meyers is recognized as an NAPW VIP Woman of the Year for her outstanding leadership and commitment within her profession. Garden City, NY (PRWEB) December 05, 2013 NAPW honors Paula J. Meyers, M.S., C.S.R.N., R.N., as a 2013/2014 Professional Woman of the Year for leadership in nursing with this prestigious distinction. As the largest, most-recognized organization of women in the country, spanning virtually every industry and profession, the National Association of Professional...

2013-12-05 23:50:36

Mental performance preserved throughout two years after catheter-based implantation of an aortic valve prosthesis Aortic valve stenosis is the most frequent heart valve defect of older people in Europe – the cause is usually increasing calcification of this important valve. In patients at high and excessive risk, conventional cardiac surgery is often no therapeutic option. For these patients, transcatheter aortic valve implantation (TAVI) remains the only opportunity. However, this...

2013-12-05 08:29:22

SOCRATES compares ticagrelor versus aspirin for the prevention of major vascular events in patients with acute ischaemic stroke or transient ischaemic attack THEMIS compares ticagrelor versus placebo for the long-term prevention of major vascular events in patients with Type 2 diabetes at high cardiovascular risk MISSISSAUGA, ON, Dec. 5, 2013 /CNW/ - AstraZeneca has announced plans to conduct two new Phase IIIb clinical studies as part of PARTHENON, the company's largest...

2013-12-03 16:25:03

XARELTO® is the Most Prescribed Novel Oral Anticoagulant in the U.S. Market Today RARITAN, N.J., Dec. 3, 2013 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that new data involving its novel oral anticoagulant XARELTO(®) (rivaroxaban) will be presented at the 55(th) American Society of Hematology (ASH) Annual Meeting and Exposition held in New Orleans, LA, USA, from December 7-10, 2013. Notable presentations at ASH's Annual Meeting and Exposition include:...

2013-12-03 12:27:31

EndoPAT(TM) Technology can identify near-future cardiovascular events post-stenting or other therapy, beyond conventional tests NEW YORK, Dec. 3, 2013 /PRNewswire/ -- Data from a new study indicate that the results of an FDA-approved test for endothelial (arterial) function significantly correlated with near-future cardiovascular events, including revascularization, chest pain, heart attack, heart failure, stroke and even death in high-risk patients, of which the majority have had...

2013-12-03 11:10:10

UCSF-led team identifies potential new risk factor for cardiovascular patients A commonly used heart monitor may be a simple tool for predicting the risk of atrial fibrillation, the most frequently diagnosed type of irregular heart rhythm, according to researchers at UC San Francisco. In a study to be published in the December 3, 2013 edition of the Annals of Internal Medicine, researchers discovered that patients who have more premature atrial contractions (PACs) detected by a routine...

2013-12-02 20:22:18

BRUSSELS, Belgium, December 3, 2013 /PRNewswire/ -- Coinciding with the World Health Organization (WHO) European Ministerial Conference on the Prevention and Control of Non-Communicable Diseases in Turkmenistan, MEPs, patient and physician representatives are today meeting at the European Parliament to highlight that urgent national action is required to prevent stroke. "Stroke is a growing burden on our healthcare services but more importantly has a devastating impact...

Motor Skills Improved After Stroke Using Novel Rehabilitation Device
2013-12-02 09:17:05

Radiological Society of North America Using a novel stroke rehabilitation device that converts an individual's thoughts to electrical impulses to move upper extremities, stroke patients reported improvements in their motor function and ability to perform activities of daily living. Results of the study were presented today at the annual meeting of the Radiological Society of North America (RSNA). "Each year, nearly 800,000 people suffer a new or recurrent stroke in the United States,...

2013-12-02 08:30:42

SENTINEL study to evaluate the Sentinel Cerebral Protection System in TAVR population SANTA ROSA, Calif., Dec. 2, 2013 /PRNewswire/ -- Claret Medical, Inc., a developer of innovative solutions for cerebral protection during structural heart interventions, vascular interventions, and cardiac surgery procedures, announced that it has submitted an investigational device exemption (IDE) application to the US Food and Drug Administration for a multicenter study of the Company's Sentinel...

2013-12-02 00:20:48

CHICAGO, Dec. 2, 2013 /PRNewswire-USNewswire/ -- Using a novel stroke rehabilitation device that converts an individual's thoughts to electrical impulses to move upper extremities, stroke patients reported improvements in their motor function and ability to perform activities of daily living. Results of the study were presented today at the annual meeting of the Radiological Society of North America (RSNA). "Each year, nearly 800,000 people suffer a new or recurrent stroke in the United...


Latest stroke Reference Libraries

Stroke
2012-05-02 19:35:56

Stroke is a peer-reviewed medical journal published monthly by Lippincott Williams & Wilkins on behalf of the American Heart Association. As of May 2012, the current editor-in-chief is Marc Fisher (University of Massachusetts Medical School). Stroke covers research on cerebral circulation and related diseases, including clinical research on assessment of risk for stroke, diagnosis, prevention, and treatment, as well as rehabilitation. The audience base for Stroke includes neurologists,...

More Articles (1 articles) »